|
COPYRIGHT 2003 Racher Press, Inc.
NEW YORK -- The switch of Schering-Plough Corp.'s Claritin from prescription to over-the-counter (O-T-C) status is shaking up the allergy category in more ways than one.
One unexpected result of the move is that some consumers may actually be paying more for the product as a result of the switch, because the nonsedating antihistamine (NSA) is no longer covered by health plans....
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
